Cargando…
The COSEHC™ Global Vascular Risk Management quality improvement program: first follow-up report
The Global Vascular Risk Management (GVRM) Study is a 5-year prospective observational study of 87,863 patients (61% females) with hypertension and associated cardiovascular risk factors began January 1, 2010. Data are gathered electronically and cardiovascular risk is evaluated using the Consortium...
Autores principales: | Ferrario, Carlos M, Joyner, JaNae, Colby, Chris, Exuzides, Alex, Moore, Michael, Simmons, Debra, Bestermann, William, Frech-Tamas, Feride |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724686/ https://www.ncbi.nlm.nih.gov/pubmed/23901282 http://dx.doi.org/10.2147/VHRM.S44950 |
Ejemplares similares
-
COSEHC global vascular risk management quality improvement program: rationale and design
por: Ferrario, Carlos M, et al.
Publicado: (2010) -
Utero-placental expression of angiotensin-(1–7) and ACE2 in the pregnant guinea-pig
por: Valdés, Gloria, et al.
Publicado: (2013) -
Vasodilator factors in the systemic and local adaptations to pregnancy
por: Valdes, Gloria, et al.
Publicado: (2009) -
Effects of a Step-Therapy Program for Angiotensin Receptor Blockers on Antihypertensive Medication Utilization Patterns and Cost of Drug Therapy
por: Yokoyama, Krista, et al.
Publicado: (2007) -
Scoping review of implementing a longitudinal curriculum in undergraduate medical education: The wake forest experience
por: Glass, Casey, et al.
Publicado: (2021)